REPORT ABUSIVE REPLY
|
Message Subject
|
Covid19/2021-22 OMICRON/ VIRUS "IHU" FRANCE:P13310/NEWEST VIRUS: "NEOCOV" HIGH INFECTION RATE+1 IN 3 DIE !?! P13315
|
Poster Handle
|
S-man |
Post Content
|
PART 3: Possible role(s) of Azithromycin: This paper has an intriguing result: [ link to link.springer.com (secure)] CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement“All patients treated with hydroxychloroquine and azithromycin had negative PCR results in nasopharyngeal samples, i.e., 100% of patients treated with both drugs were virologically cured compared to 57.1% of subjects treated with hydroxychloroquine only, and 12.5% of untreated individuals. Hydroxychloroquine and chloroquine have direct antiviral activity, as demonstrated in vitro”Remember loss of smell/taste is a key symptom? Olfactory cells get infected... Note that human olfactory cells do not express ACE2 or TMPRSS2 (known receptors used by SARS-CoV-2), but olfactory cells DO express CD147/Basigin. [ link to en.wikipedia.org (secure)] (look at the Wikipedia Basigin/CD147 page for yourself! See Malaria and SARS-CoV-2 there!? hmm.. CD147/Basigin is also thought to be a key entry point for Malaria parasites to infect red blood cells..and HCQ works against Malaria, right?? Another Azithromycin revelation:Bacteriophage-like activity observed. Then treated with Azithromycin or other antibiotics. [ link to zenodo.org (secure)] SARS-CoV-2 RNA load was reduced to negligible levels in the four aliquots treated with metronidazole, vancomycin, amoxicillin and azithromycin, respectively
|
|
Please verify you're human:
|
|
Reason for reporting:
|